Phase II Open-Label Study of Oral Piritrexim in Patients with Advanced Carcinoma of the Urothelium Who Have Experienced Failure with Standard Chemotherapy
Year: 2008
Type: article
Study design: Clinical Trial
Source: Clinical Genitourinary Cancer
Institutions: Hematology Oncology Associates, University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, U-M Rogel Cancer Center, NewYork–Presbyterian Hospital, Columbia University Irving Medical Center, Johns Hopkins University, Johns Hopkins Hospital
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Institute on Aging
OpenAlex ID: W1995550327
